1. McDowell LJ, Rock K, Xu W, Chan B, Waldron J, Lu L, et al. Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2018;102(2):340-52.
2. Boomsma MJ, Bijl HP, Langendijk JA. Radiation-induced hypothyroidism in head and neck cancer patients: a systematic review. Radiother Oncol. 2011;99(1):1-5.
3. Vogelius IR, Bentzen SM, Maraldo MV, Petersen PM, Specht L. Risk factors for radiation-induced hypothyroidism: a literature-based meta-analysis. Cancer. 2011;117(23):5250-60.
4. Jereczek-Fossa BA, Alterio D, Jassem J, Gibelli B, Tradati N, Orecchia R. Radiotherapy-induced thyroid disorders. Cancer Treat Rev. 2004;30(4):369-84.
5. Biondi B, Cappola AR, Cooper DS. Subclinical Hypothyroidism: A Review. JAMA. 2019;322(2):153-60.
6. Pinnix CC, Cella L, Andraos TY, Ayoub Z, Milgrom SA, Gunther J, et al. Predictors of Hypothyroidism in Hodgkin Lymphoma Survivors After Intensity Modulated Versus 3-Dimensional Radiation Therapy. Int J Radiat Oncol Biol Phys. 2018;101(3):530-40.
7. Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin's disease. New England Journal of Medicine. 1991;325(9):599-605.
8. Bhandare N, Kennedy L, Malyapa RS, Morris CG, Mendenhall WM. Primary and Central Hypothyroidism After Radiotherapy for Head-and-Neck Tumors. International Journal of Radiation Oncology*Biology*Physics. 2007;68(4):1131-9.
9. D LCP, D MCM, D MCM, De Rosa M D N, D RLP, D MPM, et al. Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin’s lymphoma. Radiation Oncology Biology. 2012;82(5):1802-8.
10. Cella L, Liuzzi R, Conson M, D'Avino V, Salvatore M, Pacelli R. Development of multivariate NTCP models for radiation-induced hypothyroidism: a comparative analysis. Radiat Oncol. 2012;7(1):224.
11. Boomsma MJ, Bijl HP, Christianen MEMC, Beetz I, Chouvalova O, Steenbakkers RJHM, et al. A Prospective Cohort Study on Radiation-induced Hypothyroidism: Development of an NTCP Model. International Journal of Radiation Oncology*Biology*Physics. 2012;84(3):e351-e6.
12. Rønjom MF, Brink C, Bentzen SM, Hegedüs L, Overgaard J, Johansen J. Hypothyroidism after primary radiotherapy for head and neck squamous cell carcinoma: Normal tissue complication probability modeling with latent time correction. Radiotherapy and Oncology. 2013;109(2):317-22.
13. Luo R, Wu VWC, He B, Gao X, Xu Z, Wang D, et al. Development of a normal tissue complication probability (NTCP) model for radiation-induced hypothyroidism in nasopharyngeal carcinoma patients. BMC Cancer. 2018;18(1):575.
14. Fan C-Y, Lin C-S, Chao H-L, Huang W-Y, Su Y-F, Lin K-T, et al. Risk of hypothyroidism among patients with nasopharyngeal carcinoma treated with radiation therapy: a population-based cohort study. Radiotherapy and Oncology. 2017;123(3):394-400.
15. Ipekci SH, Cakir M, Kiyici A, Koc O, Artac M. Radiotherapy-induced hypopituitarism in nasopharyngeal carcinoma: the tip of an iceberg. Exp Clin Endocrinol Diabetes. 2015;123(7):411-8.
16. Wu YH, Wang HM, Chen HH, Lin CY, Chen EY, Fan KH, et al. Hypothyroidism after radiotherapy for nasopharyngeal cancer patients. Int J Radiat Oncol Biol Phys. 2010;76(4):1133-9.
17. Darzy KH. Radiation-induced hypopituitarism. Curr Opin Endocrinol Diabetes Obes. 2013;20(4):342-53.
18. Zhai RP, Kong FF, Du CR, Hu CS, Ying HM. Radiation-induced hypothyroidism after IMRT for nasopharyngeal carcinoma: Clinical and dosimetric predictors in a prospective cohort study. Oral Oncol. 2017;68:44-9.
19. Lin Z, Yang Z, He B, Wang D, Gao X, Tam SY, et al. Pattern of radiation-induced thyroid gland changes in nasopharyngeal carcinoma patients in 48 months after radiotherapy. PLoS ONE. 2018;13(7):e0200310.
20. Siala W, Mnejja W, Abid M, Ghorbel A, Frikha M, Daoud J, editors. Thyroid toxicity after radiotherapy of nasopharyngeal carcinoma. Annales d'Endocrinologie; 2011: Elsevier.
21. Appelman-Dijkstra NM, Malgo F, Neelis KJ, Coremans I, Biermasz NR, Pereira AM. Pituitary dysfunction in adult patients after cranial irradiation for head and nasopharyngeal tumours. Radiother Oncol. 2014;113(1):102-7.
22. Lam K, Tse V, Wang C, Yeung R, Ho J. Effects of Cranial Irradiation on Hypothalamic—Pituitary Function—a 5-Year Longitudinal Study in Patients with Nasopharyngeal Carcinoma. QJM: An International Journal of Medicine. 1991;78(2):165-76.
23. Bhandare N, Kennedy L, Malyapa RS, Morris CG, Mendenhall WM. Hypopituitarism after radiotherapy for extracranial head and neck cancers. Head & Neck: Journal for the Sciences and Specialties of the Head and Neck. 2008;30(9):1182-92.
24. Ratnasingam J, Karim N, Paramasivam SS, Ibrahim L, Lim LL, Tan AT, et al. Hypothalamic pituitary dysfunction amongst nasopharyngeal cancer survivors. Pituitary. 2015;18(4):448-55.
25. Appelman-Dijkstra NM, Kokshoorn NE, Dekkers OM, Neelis KJ, Biermasz NR, Romijn JA, et al. Pituitary dysfunction in adult patients after cranial radiotherapy: systematic review and meta-analysis. The Journal of Clinical Endocrinology & Metabolism. 2011;96(8):2330-40.
26. Littley M, Shalet SM, Beardwell CG, Robinson E, Sutton CL. Radiation‐induced hypopituitarism is dose‐dependent. Clin Endocrinol. 1989;31(3):363-73.
27. Lee AW, Ng WT, Pan JJ, Chiang CL, Poh SS, Choi HC, et al. International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys. 2019;105(3):567-80.
28. Beck-Peccoz P, Rodari G, Giavoli C, Lania A. Central hypothyroidism - a neglected thyroid disorder. Nat Rev Endocrinol. 2017;13(10):588-98.
29. Rose SR. Cranial irradiation and central hypothyroidism. Trends in Endocrinology & Metabolism. 2001;12(3):97-104.
30. Miller MC, Agrawal A. Hypothyroidism in postradiation head and neck cancer patients: incidence, complications, and management. Curr Opin Otolaryngol Head Neck Surg. 2009;17(2):111-5.
31. Diaz R, Jaboin JJ, Morales-Paliza M, Koehler E, Phillips JG, Stinson S, et al. Hypothyroidism as a Consequence of Intensity-Modulated Radiotherapy With Concurrent Taxane-Based Chemotherapy for Locally Advanced Head-and-Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 2010;77(2):468-76.
32. Colevas AD, Read R, Thornhill J, Adak S, Tishler R, Busse P, et al. Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck. International Journal of Radiation Oncology*Biology*Physics. 2001;51(3):599-604.
33. Nishiyama K, Kozuka T, Higashihara T, Miyauchi K, Okagawa K. Acute radiation thyroiditis. International Journal of Radiation Oncology* Biology* Physics. 1996;36(5):1221-4.
34. Bakhshandeh M, Hashemi B, Mahdavi SRM, Nikoofar A, Vasheghani M, Kazemnejad A. Normal Tissue Complication Probability Modeling of Radiation-Induced Hypothyroidism After Head-and-Neck Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 2013;85(2):514-21.
35. Fujiwara M, Kamikonya N, Odawara S, Suzuki H, Niwa Y, Takada Y, et al. The threshold of hypothyroidism after radiation therapy for head and neck cancer: a retrospective analysis of 116 cases. J Radiat Res. 2015;56(3):577-82.
36. Sommat K, Ong WS, Hussain A, Soong YL, Tan T, Wee J, et al. Thyroid V40 Predicts Primary Hypothyroidism Following Intensity Modulated Radiotherapy for Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys. 2017:1-24.
37. Sachdev S, Refaat T, Bacchus ID, Sathiaseelan V, Mittal BB. Thyroid V50 Highly Predictive of Hypothyroidism in Head-and-Neck Cancer Patients Treated With Intensity-modulated Radiotherapy (IMRT). Am J Clin Oncol. 2014:1-5.
38. Chyan A, Chen J, Shugard E, Lambert L, Quivey JM, Yom SS. Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy. Radiat Oncol. 2014;9(1):269-7.
39. Kim MY, Yu T, Wu HG. Dose-volumetric parameters for predicting hypothyroidism after radiotherapy for head and neck cancer. Jpn J Clin Oncol. 2014;44(4):331-7.
40. Lee V, Chan S-Y, Choi C-W, Kwong D, Lam K-O, Tong C-C, et al. Dosimetric Predictors of Hypothyroidism After Radical Intensity-modulated Radiation Therapy for Non-metastatic Nasopharyngeal Carcinoma. Clinical Oncology. 2016;28(8):e52-e60.